Investing-News.Com
Information for Investors

ALBANY MOLECULAR, (AMRI) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

ALBANY MOLECULAR, (AMRI) Stock Research Free Stock Rating

 
Company Profile
 
Albany Molecular Research, Inc. operates as a chemistry-based drug discovery and development company. It develops small molecule prescription drugs. Albany offers drug lead discovery, medicinal chemistry, chemical development, and analytical chemistry services. The company conducts research and development projects; and collaborates with various pharmaceutical, biotechnology, and genomics companies. It also provides discovery technologies, including isolation, purification, structure elucidation, and sample collection libraries from microbial and botanical sources, computational chemistry, virtual screening, microbiology, fermentation, asymmetric synthesis, and high throughput metabolic screening. The company offers its services to pharmaceutical companies, biotechnology companies, agricultural companies, fine chemical companies, and contract chemical manufacturers. Albany Molecular Research was founded in 1991 and is based in Albany, New York.

ALBANY MOLECULAR Related

AMRI - Albany Molecular Research - AMRI Founded in 1991 as Albany Molecular Research, Inc. ... CONTACT US | DIRECTIONS | SITE MAP | DISCLAIMER © AMRI - Albany Molecular Research, 2008. ...
AMRI - Albany Molecular Research: Careers: AMRI, Albany Molecular ... Founded in 1991 as Albany Molecular Research, Inc. ... © AMRI - Albany Molecular Research, 2008. All rights reserved. Monday, November 24, 2008 ...
Albany Molecular Research, Inc (AMRI) Albany Molecular has recently set a new 52-week high after a great second-quarter report. ... Albany molecular now expects between 48 and 52 cents per share, ...
Sponsored Links:

Software Forces ALBANY MOLECULAR Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in ALBANY MOLECULAR buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on ALBANY MOLECULAR. This software is specially designed to give precision entry and exit points on ALBANY MOLECULAR, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When ALBANY MOLECULAR Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even ALBANY MOLECULAR, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: gib stock analysis  john butters - thomson financial  online stock trading company  online trading card price guide 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Achievement Awards - Clint Ballinger (at bizjournals.com)

AMRI settles patent dispute with rivals (at bizjournals.com)

Israel Stocks: Market lower; Teva settles patent case, wins a round in another (at MarketWatch)

ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosur (EDGAR Online)

Teva, Barr settle patent dispute with Sanofi (AP)

Teva, Barr, Sanofi, Albany Molecular settle patent disputes (at MarketWatch)

AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Litigation in ALLEGRA® and ALLEGRA®D-12 U.S. Patent Dispute (Business Wire)

Albany Molecular Research, Inc. Q3 2008 Earnings Call Transcript (at Seeking Alpha)

ALBANY MOLECULAR RESEARCH INC Financials (EDGAR Online Financials)

ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.